Sleep issues in gastroesophageal reflux disease: Beyond simple heartburn control

Reviews in Gastroenterological Disorders

Volumn 3, Issue SUPPL. 4, 2003, Pages

  Orr, William C ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Gastroesophageal reflux; Nocturnal GER; Sleep

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ARTICLE; ASTHMA; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; ESOPHAGITIS; ESOPHAGUS MOTILITY; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LUNG ASPIRATION; NONREM SLEEP; PATHOPHYSIOLOGY; REM SLEEP; RISK ASSESSMENT; SALIVATION; SLEEP; STOMACH ACID SECRETION; STOMACH MOTILITY; STOMACH PH; SWALLOWING; THERMOREGULATION;

ANTACIDS; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; OMEPRAZOLE; PROTON PUMPS; QUALITY OF LIFE; SLEEP;

EID: 0346271505     PISSN: 1533001X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Carskadon MA, Dement WC. Normal human sleep: An overview. In: Kryger M, Roth T, Dement WC, eds. Principles and practices of sleep medicine. Philadelphia, PA: WB Saunders Company; 1994:16-25.
2. Siegel JM. Mechanisms of sleep control. J Clin Neurophysiol. 1990;7:49-65.
3. Freidin N, Fisher MJ, Taylor W, et al. Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis. Gut. 1991; 32:1275-1279.
4. DeMeester TR, Johnson LF, Joseph GJ, et al. Patterns of gastroesophageal reflux in health and disease. Ann Surg. 1976;184:459-470.
5. Orr WC, Allen ML, Robinson M. The pattern of nocturnal and diurnal esophageal acid exposure in the pathogenesis of erosive mucosal damage. Am J Gastroenterol. 1994;89:509-512.
6. Orr WC, Robinson MG, Johnson LF. Acid clearance during sleep in the pathogenesis of reflux esophagitis. Dig Dis Sci. 1981;26:423-427.
7. Johnson LF, Harmon JW. Experimental esophagitis in a rabbit model; clinical relevance. J Clin Gastroenterol. 1986;8(suppl. 1):26-44.
8. Orr WC, Elsenbruch S, Harnish MJ, Johnson LF. Proximal migration of esophageal acid perfusions during waking and sleep. Am J Gastroenterol. 2000;95:37-42.
9. Orr WC, Johnson LF, Robinson MG. Effect of sleep on swallowing, esophageal peristalsis, and acid clearance. Gastroenterology. 1984;85:814-819.
10. Mays EE, Dubois JJ, Hamilton GB. Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest. 1976;69:512-515.
11. David P, Denis P, Nouvet G, Pasquis P, Lefrancois R, Morere P. Lung function and gastroesophageal reflux during chronic bronchitis. Bull Eur Physiopathol Respir. 1983;18:81-86.
12. Ing AJ, Ngu MC, Breslin AB. Obstructive sleep apnea and gastroesophageal reflux. Am J Med. 2000;108(Suppl 4a):120S-125S.
13. Orr WC. Sleep-related breathing disorders: Is it all about apnea? Chest. 2002; 121:8-11.
14. Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: The results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Amer J Gastroenterol. July 2003;1487-1493.
15. Farup C, Kleinman L, Sloan S, et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med. 2001;161:45-52.
16. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831.
17. Sontag SJ. Gastroesophageal reflux disease and asthma. J Clin Gastroenterol. 2000;39(suppl):S9-S30.
18. Cuttitta G, Cibella F, Visconti A, et al. Spontaneous gastroesophageal reflux and airway patency during the night in adult asthmatics. Am J Crit Care Med. 2000;Vol 161:177-181.
19. Harding SM. Nocturnal asthma: role of nocturnal gastroesophageal reflux. Chronobiol Int. 1999; 16(5):641-642.
20. Gisalson T, Janson C, Vermeire P, et al. Respiratory symptoms and nocturnal gastroesophageal reflux. Chest. 2002;121:158-163.
21. Rajaratnam SM, Arendt J. Health in a 24-h society. Lancet. 2001;358:999-1005.
22. Johnson LF, DeMeester TR. Evaluation of elevation of the head of the bed, bethanechol, and antacid form tablets on gastroesophageal reflux. Dig Dis Sci. 1981;26:673-680.
23. Galmiche JP, Letessier E, Scarpignato C. Treatment of gastro-oesophageal reflux disease in adults. BMJ. 1998;316(7146):1720-1723.
24. Chiba N, DeGara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptoms relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. Gastroenterol. 1997;112(6):1798-1810.
25. Kahrilas P, Falk G, Johnson D, et al. Esomeprazole improves healing and symptoms resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Ali Pharm Ther. 2000;14:1249-1258.
26. Castell D, Kahrilas P, Richter J, et al. Esomeprazole (40mg) compared with lansoprazole (30mg) in the treatment of erosive esophagitis. Am J Gastroenterol. 2002;97(3):575-583.
27. Scholten T, Gatz G, Hole U. Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms. Aliment Pharmacol Ther. 2003; 18:587-594.
28. Hatlebakk JG, Katz PO, Kuo B, Castell DO. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther. 1998;12:1235-1240.
29. Wilder-Smith C, Lind T, Lundin C, et al. Comparison of esomeprazole (20, 40, 80 mg) versus lansoprazole (15, 30, and 60 mg) on intragastric pH in healthy subjects. Gastroenterology. 2003;124:A444.
30. Miner PB Jr, Katz PO, Chen Y, Sostek MB. Esomeprazole 40 mg provides more effective intragastric acid suppression at steady state than standard doses of other proton pump inhibitors. Gastroenterology. 2003;124:A229.